Shuwang Ge
Impact in
- Nephrology top 0.5%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Nephrology 29
- Renal Diseases and Glomerulopathies 14
- Chronic Kidney Disease and Diabetes 11
- Acute Kidney Injury Research 8
- Dialysis and Renal Disease Management 6
- Immunology 17
- IL-33, ST2, and ILC Pathways 4
- Co-authors
- Gang XuRan LuoYichun ChengYing YaoLei DongJunhua LiZhixiang WangMeng Zhang
- Journals
- PLoS ONE (6 papers)BMC Nephrology (4 papers)American Journal of Nephrology (4 papers)Renal Failure (3 papers)Frontiers in Medicine (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Shuwang Ge
61 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Nephrology 721
- Infectious Diseases 1.6k
- Neurology 672
- Oncology 763
- Obstetrics and Gynecology 177
Countries citing papers authored by Shuwang Ge
This map shows the geographic impact of Shuwang Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuwang Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuwang Ge more than expected).
Fields of papers citing papers by Shuwang Ge
This network shows the impact of papers produced by Shuwang Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuwang Ge. The network helps show where Shuwang Ge may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuwang Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 17 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 29 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 5 | |
| 17 | 2016 | 35 | |
| 18 | 2016 | 26 | |
| 19 | 2012 | 28 | |
| 20 | 2011 | 20 |
About Shuwang Ge
Shuwang Ge is a scholar working on Nephrology, Immunology, Rheumatology, Infectious Diseases and Oncology, having authored 66 papers that have together received 3.0k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (11 papers), Systemic Lupus Erythematosus Research (8 papers), Acute Kidney Injury Research (8 papers), Dialysis and Renal Disease Management (6 papers), COVID-19 Clinical Research Studies (6 papers), Nutritional Studies and Diet (5 papers) and IL-33, ST2, and ILC Pathways (4 papers). The work is most often cited by research in Nephrology (721 citations), Infectious Diseases (1.6k citations), Neurology (672 citations), Oncology (763 citations) and Obstetrics and Gynecology (177 citations). Shuwang Ge has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Gang Xu, Ran Luo, Yichun Cheng, Ying Yao, Lei Dong, Junhua Li, Zhixiang Wang, Meng Zhang, Kun Wang and Rui Zeng. Their work appears in journals such as PLoS ONE, BMC Nephrology, American Journal of Nephrology, Renal Failure and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.